ESR1 and androgen insensitivity syndrome: Estrogen acts on target cells through estrogen receptor 1 (ESR1) or 2 (ESR2) (Kuiper et al., 1996) and genetic mutations in both ESR1 and 2 are associated with the risk of AIS development (Wang et al., 2020a).